Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
- University of Basel
- ETH Zürich
- Empa
- Paul Scherrer Institut Villigen
- Nature Careers
- University of Zurich
- Adolphe Merkle Institute
- EPFL - Ecole Polytechnique Fédérale de Lausanne
- ETH Zurich
- Ecole Polytechnique Federale de Lausanne
- Idiap Research Institute
- Swiss Federal Institute for Forest, Snow and Landscape Research WSL
- University of Geneva
- Universität Bern
- 4 more »
- « less
-
Field
-
for applications ranging from magnetoelectronic devices to advanced biomedical systems. A central strength of our group is the development and operation of unique, home-built scanning probe microscopy platforms
-
of the calls, and the application procedure, please consult the applications guidelines on the website of the AXA Research Fund.
-
of fluoride and hydrofluoric acid species during battery operation Coupling of the individual online measurement techniques and development of an appropriate control procedure Maintenance of processing and
-
materials, and experience with sol/gel processes, biomolecule handling and release studies high motivation to work in an interdisciplinary project excellent skills at science communication (verbal and written
-
energy-related applications. Our research portfolio spans fundamental materials chemistry, process–structure–property relationships, and application-driven R&D, in close collaboration with academic and
-
received by 1 November 2025. Note: as an option, one of the four reference letters can be about teaching. For more details, please see the website: https://math.ethz.ch/fim/postdocs.html Application
-
–2028 cycle will open in November 2026. Help Us Improve Our Fellowship Application Process We noticed that some applicants began the application process but did not submit their application
-
, entitled "Patient-specific hydrogelbased corneal augmentation for vision restoration" is to restore the vision of patients by using an advanced optical system capable of preparing and processing the cornea.
-
role of drug transporters and drug-metabolizing enzymes in these processes. Both transporters and enzymes are influenced by multiple factors, including naturally occurring genetic variants, which
-
maintenance of neuroinflammatory processes and identify molecular targets that could serve as the basis for future therapies. To that end, we combine human studies with experimental (gnotobiotic) murine models